97190 ⎘
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against prion molecules, e.g. CD230
ANTI-DOPPEL ANTIBODY DRUG CONJUGATES
#2PHARMACEUTICAL COMPOSITION COMPRISING PRION PROTEIN-SPECIFIC ANTIBODY
#3COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF PRION DISEASE
#4Innocuous, structured scaffolds for structure-based amyloid disease vaccines and antigens
#5TETZ-PROTEINS AND PRION-LIKE PROTEINS AND ASSOCIATED METHODS
#6Method for treating a neurodegenerative disease by administering an anti-cellular prion protein (PrP) antibody
#7LIGANDS BINDING TO PRION PROTEIN FOR USE IN THE TREATMENT OF SYNUCLEINOPATHIES
#8Prion protein antibodies for the treatment of Alzheimer's disease
#9Anti-PrP antibodies and uses thereof
#10Monoclonal antibody to treat alzheimer's disease, prion disease, frontotemporal dementias and traumatic brain injury/chronic traumatic encephalopathy
#11CELL SENESCENCE MARKERS AS DIAGNOSTIC AND THERAPEUTIC TARGETS
#12Methods of inhibiting pathological angiogenesis with doppel-targeting molecules
#13Methods of inhibiting pathological angiogenesis with doppel-targeting molecules
#14Prion protein antibodies for the treatment of Alzheimer's disease
#15Monoclonal antibody against human PrPc and use thereof
#16Synthetic antiserum for rapid-turnaround therapies
#17FasR antibodies and methods of use
#18Prion Protein as a Receptor for Amyloid-Beta Oligomers
#19Methods and systems for predicting misfolded protein epitopes
#20CELL SENESCENCE MARKERS AS DIAGNOSTIC AND THERAPEUTIC TARGETS
#21Prion epitopes and methods of use thereof
#22Antibodies and conjugates that target misfolded prion protein
#23PRION PROTEIN ANTIBODIES FOR THE TREATMENT OF ALZHEIMER'S DISEASE
#24High-affinity monoclonal anti-prion antibodies
#25Antibodies And Epitopes Specific To Misfolded Prion Protein
#26ENRICHMENT AND PURIFICATION OF INFECTIOUS PRION PROTEINS
#27MISFOLDED PROTEINS IN CANCER TREATMENT AND DIAGNOSIS
#28Anti-prion protein antibody fragment
#29NOVEL ANTIBODIES AGAINST PRION PROTEIN AND USES THEREOF
#30TREATMENT OF PRION PROTEIN RELATED DISEASES
#31Prion protein as a receptor for amyloid-β oligomers
#32RAPID ANTEMORTEM DETECTION OF INFECTIOUS AGENTS
#33METHODS AND SYSTEMS FOR PREDICTING MISFOLDED PROTEIN EPITOPES
#34Prion epitopes and methods of use thereof
#35MISFOLDED PROTEINS IN CANCER TREATMENT AND DIAGNOSIS
#36Antibodies for discrimination of prions
#37Methods Kits and Compositions for the Developement and Use of Monoclonal Antibodies Specific to Anbtigens of Low Immunogenicity
#38Biological materials and methods useful in the diagnosis and treatment of diseases
#39Degradation and detection of TSE infectivity
#40Immunoassay for Prion Disease
#41Anti-Lipid Rafts Antibodies
#42Use of monoclonal antibodies to distinguish protein conformational isoforms
#43Anti-abnormal type prion monoclonal antibody, process for producing the same, and immunoassay of abnormal type prion protein using the same
#44Remedy for prion disease and method of producing the same
#45ANTIBODIES SPECIFIC FOR UNGULATE PrP
#46Calpains as targets for inhibition of prion propagation
#47Biological materials and methods useful in the diagnosis and treatment of diseases
#48Immunological detection of prions